The SBC Catalyser Programme

Do you have a winning commercialisation strategy?

2024 PROGRAMME: 12 Mar - 1 May

Applications are CLOSED

The Catalyser programme helps companies innovating in human health refine their commercialisation strategy through a journey involving the analysis of 9 meso-economic vectors from the Triple Chasm framework.

From the programme, the selected companies will gain:

  • a refined commercialization strategy
  • a clear execution plan
  • access to experts, potential partners and investors

The 6 highly-interactive sessions cover the strategy vectors:

  • Market Space Definition
  • Proposition Framing + Customer Definition
  • Tech Management + IP Management
  • Product Synthesis + Human Capital
  • Funding Strategy + Strategic Positioning
  • Final Presentations and Feedback

Each session includes:

  • review of each startup strategy on previous vector 
  • presentation of Triple Chasm framework for the current vector
  • introduction to Triple Chasm tools to help project the theory onto each startup case
  • panel discussion with 3 industry experts to help understand real world scenarios and trend

WHY you should apply

The SBC Catalyser programme provides:

  • A comprehensive commercial strategy to go from idea to prototype
  • A clear execution plan to translate the strategy into action
  • Free virtual tenancy at SBC for 12 months, including access to the SBC events and a community including GSK, the Cell and Gene Therapy Catapult (CGTC) and over 40+ life sciences companies
  • Free labspace and access to specialised equipment for 6 months awarded to best performing teams
  • A strategically aware leadership team, able to evolve their commercialisation strategies in response to changes in markets and technologies
  • An enhanced company profile
  • Improved chances of getting the right funding at the right time

HOW to achieve your goals

The programme includes:

  • 6 highly-interactive sessions to cover 8 strategy vectors
  • A set of 25 strategy-profiling tools to design your path to success
  • 5 panel discussions featuring 15+ industry leaders 
  • Access to the SBC community, including a world class team of mentors and experts, investors and partners

WHO you are

  • You are developing innovations for the benefit of human health
  • You are en route to building a first proof of concept
  • You have integrated digital and data technologies (ie ML/AI) in your R&D workflow, or you are planning to integrate them
  • You have an existing presence in the UK, or you are planning to establish a presence in the UK
  • You have an ambitious leadership team of at least 2-3 that can commit to full participation in the programme

WHO we are

  • Campus of 40+ therapeutics companies and largest cluster of CGT companies in Europe
  • Companies based at SBC have raised more than £3bn since SBC's birth in 2012, including 8 exits
  • Our campus also includes GSK, LifeArc, CGTC and Cytiva
  • We provide lab-space, office-space and business development support to our occupiers
  • Our Lab Hotel provides free lab-space for 6 months to 7 selected early-stage companies

Read our Economic Impact Assessment report for more information.

Delivered in Collaboration with:

Click here for information on the 2021 "DATA Programme"

Learn more about Catalyser

Spaces are limited to maximum 10 companies per cohort, learn more about our next programme by writing to

Learn More

We use cookies to improve our site experience. Press accept to agree to our Cookie Policy. If you decline, your information won’t be tracked when you visit this website. A single cookie will be used in your browser to remember your preference not to be tracked.